Abstract
The key precursor, N2-(N,N-dimethylaminomethylene)-6- hydroxymethyl-8-methyl-3-[2-(4-nitrophenyl) ethyl]-7-xanthopterin (16) was efficiently prepared from 2,5-diamino-6-methylamino-3 H-pyrimidin-4-one (5) and ethyl 3-(tert-butyldimethylsilyloxy)-2-oxopropionate (12), followed by the protection of the pteridine ring. Glycosylation of 16 with 1-O-acetyl-2,3,5-tri- O-benzoyl-β-D-ribofuranose (18) in the presence of tin(IV) chloride yielded the corresponding β-D-ribofuranoside. Successive removal of the protecting groups of the resulting D-ribofuranoside provided asperopterin A (4b).
Original language | English |
---|---|
Pages (from-to) | 3-6 |
Number of pages | 4 |
Journal | Pteridines |
Volume | 24 |
Issue number | 1 |
DOIs | |
Publication status | Published - Jun 2013 |
Keywords
- Asperopterin
- Glycosylation
- Isoxanthopterin
- Protecting groups
- Pterin glycoside
ASJC Scopus subject areas
- Biochemistry
- Molecular Medicine
- Clinical Biochemistry